These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

458 related items for PubMed ID: 23522403

  • 21. Role of macrolide therapy in chronic obstructive pulmonary disease.
    Martinez FJ, Curtis JL, Albert R.
    Int J Chron Obstruct Pulmon Dis; 2008; 3(3):331-50. PubMed ID: 18990961
    [Abstract] [Full Text] [Related]

  • 22. The role of atypical infections and macrolide therapy in patients with asthma.
    Rollins DR, Good JT, Martin RJ.
    J Allergy Clin Immunol Pract; 2014; 2(5):511-7. PubMed ID: 25213043
    [Abstract] [Full Text] [Related]

  • 23. Long-term macrolide therapy in chronic inflammatory airway diseases.
    Crosbie PA, Woodhead MA.
    Eur Respir J; 2009 Jan; 33(1):171-81. PubMed ID: 19118228
    [Abstract] [Full Text] [Related]

  • 24. [Inhaled antibiotics in the treatment of noncystic fibrosis bronchiectasis].
    Martínez García MÁ, Soler Cataluña JJ, Serra PC.
    Arch Bronconeumol; 2011 Jun; 47 Suppl 6():19-23. PubMed ID: 21703475
    [Abstract] [Full Text] [Related]

  • 25. [Antibiotic therapy in asthma exacerbation and in cystic fibrosis in children].
    Breborowicz A.
    Pol Merkur Lekarski; 2011 May; 30(179):349-51. PubMed ID: 21675140
    [Abstract] [Full Text] [Related]

  • 26. Inhaled antibiotics for lower airway infections.
    Quon BS, Goss CH, Ramsey BW.
    Ann Am Thorac Soc; 2014 Mar; 11(3):425-34. PubMed ID: 24673698
    [Abstract] [Full Text] [Related]

  • 27. Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.
    Zarogoulidis P, Papanas N, Kioumis I, Chatzaki E, Maltezos E, Zarogoulidis K.
    Eur J Clin Pharmacol; 2012 May; 68(5):479-503. PubMed ID: 22105373
    [Abstract] [Full Text] [Related]

  • 28. Antibiotic therapy for stable non-CF bronchiectasis in adults - A systematic review.
    Fjaellegaard K, Sin MD, Browatzki A, Ulrik CS.
    Chron Respir Dis; 2017 May; 14(2):174-186. PubMed ID: 27507832
    [Abstract] [Full Text] [Related]

  • 29. Anti-inflammatory effects of macrolides in lung disease.
    Jaffé A, Bush A.
    Pediatr Pulmonol; 2001 Jun; 31(6):464-73. PubMed ID: 11389580
    [Abstract] [Full Text] [Related]

  • 30. Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators.
    Giamarellos-Bourboulis EJ.
    Int J Antimicrob Agents; 2008 Jan; 31(1):12-20. PubMed ID: 17935949
    [Abstract] [Full Text] [Related]

  • 31. Prolonged treatment with macrolides in adult patients with non-cystic fibrosis bronchiectasis: meta-analysis of randomized controlled trials.
    Zhuo GY, He Q, Xiang-Lian L, Ya-Nan Y, Si-Te F.
    Pulm Pharmacol Ther; 2014 Oct; 29(1):80-8. PubMed ID: 24594263
    [Abstract] [Full Text] [Related]

  • 32. Inhaled antibiotics for lower respiratory tract infections: focus on ciprofloxacin.
    Serisier DJ.
    Drugs Today (Barc); 2012 May; 48(5):339-51. PubMed ID: 22645722
    [Abstract] [Full Text] [Related]

  • 33. Macrolide antibiotics and bronchiolitis obliterans following lung transplantation.
    Crowley S, Egan JJ.
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):923-30. PubMed ID: 16307505
    [Abstract] [Full Text] [Related]

  • 34. Immunomodulatory effects of macrolide antibiotics - part 2: advantages and disadvantages of long-term, low-dose macrolide therapy.
    Altenburg J, de Graaff CS, van der Werf TS, Boersma WG.
    Respiration; 2011 Dec; 81(1):75-87. PubMed ID: 20733282
    [Abstract] [Full Text] [Related]

  • 35. Immunomodulatory effects of macrolide antibiotics in respiratory disease: therapeutic implications for asthma and cystic fibrosis.
    Sharma S, Jaffe A, Dixon G.
    Paediatr Drugs; 2007 Dec; 9(2):107-18. PubMed ID: 17407366
    [Abstract] [Full Text] [Related]

  • 36. A review of non-cystic fibrosis bronchiectasis in children with a focus on the role of long-term treatment with macrolides.
    El Boustany P, Gachelin E, Colomban C, Cernoia J, Sudour P, Carsin A, Dubus JC.
    Pediatr Pulmonol; 2019 Apr; 54(4):487-496. PubMed ID: 30652424
    [Abstract] [Full Text] [Related]

  • 37. Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Greally P, Whitaker P, Peckham D.
    Curr Med Res Opin; 2012 Jun; 28(6):1059-67. PubMed ID: 22401602
    [Abstract] [Full Text] [Related]

  • 38. Is there a role for macrolides in severe asthma?
    Brusselle GG, Joos G.
    Curr Opin Pulm Med; 2014 Jan; 20(1):95-102. PubMed ID: 24247040
    [Abstract] [Full Text] [Related]

  • 39. Neomacrolides in the treatment of patients with severe asthma and/or bronchiectasis: a retrospective observational study.
    Coeman M, van Durme Y, Bauters F, Deschepper E, Demedts I, Smeets P, Joos G, Brusselle G.
    Ther Adv Respir Dis; 2011 Dec; 5(6):377-86. PubMed ID: 21890536
    [Abstract] [Full Text] [Related]

  • 40. [Long-term macrolide treatment in adult chronic bronchial diseases: benefits and limits].
    Jouneau S, Desrues B.
    Presse Med; 2014 May; 43(5):510-9. PubMed ID: 24631048
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.